Kerri Urhahn Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1750 S Perryville Blvd, Perryville, MO 63775 Phone: 573-547-2571 |
Dr. Danielle Landholt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 S Perryville Blvd, Perryville, MO 63775 Phone: 573-517-0029 Fax: 573-517-0319 |
Dana Cover, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Hospital Ln Ste 102, Perryville, MO 63775 Phone: 573-547-4960 Fax: 573-547-6540 |
Dr. Karen Roth, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Hospital Ln Ste 102, Perryville, MO 63775 Phone: 573-547-4960 Fax: 573-547-6540 |
Dr. Kelsey Cissell, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1750 S Perryville Blvd, Perryville, MO 63775 Phone: 573-547-2577 |
David Keith Zweigart Ii Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 S Perryville Blvd, Perryville, MO 63775 Phone: 573-517-0029 |
Dr. Shannon Elizabeth Bulla, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Hospital Ln, Perryville, MO 63775 Phone: 573-547-4960 |
Amanda Wozniak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Hospital Ln Ste 102, Perryville, MO 63775 Phone: 573-547-4960 Fax: 573-547-6540 |
News Archive
Ben-Gurion University of the Negev (BGU) researchers have unraveled the genetic basis of a hereditary disease that causes severe brain atrophy, mental retardation and epilepsy in Jews of Moroccan ancestry, according to a study published this week online in the Journal of Medical Genetics.
It took a reporter's intervention to obtain coverage for a Chicago resident who had touted the law's benefits at a news conference last year but who had been mired in computer and other problems. Other reports look at how free preventive services may reduce health disparities and whether insurers can charge higher premiums to those who smoke e-cigarettes.
Some patients with a form of advanced kidney cancer that carries a poor prognosis benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by a Dana-Farber Cancer Institute scientist.
LTC Properties, Inc. announced today that it had declared the quarterly cash dividend of $0.50 per share on the Company's 8.0% Series F Cumulative Preferred Stock. The dividend is payable on October 15, 2010 to stockholders of record on October 1, 2010.
› Verified 4 days ago